Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Assessing, preserving and restoring man-microbes symbiosis

Descripción del proyecto

Mejorar el microbioma del intestino humano

El microbioma humano alberga una comunidad de microorganismos. Las investigaciones han demostrado que un microbioma intestinal diverso implica un microbioma más sano, por lo que realiza una contribución esencial a nuestra salud. Cerca de una tercera parte de la población experimenta un desequilibro del microbioma intestinal (disbiosis). Este estado se caracteriza por la alteración de las interacciones entre microbios simbióticos y su huésped. Eso podría provocar enfermedades inmunitarias incurables para las cuales las terapias actuales solo abordan el alivio de los síntomas. El proyecto Homo.symbiosus financiado con fondos europeos, planea desarrollar nuevos métodos terapéuticos basados en la ecología del intestino para restaurar la simbiosis persona-microbio.

Objetivo

The microbiomics revolution has favoured the recognition of the gut as a true organ and the importance of man-microbes symbiosis in health and disease. Derived from a long co-evolution the latter has been challenged by numerous environmental triggers, modern lifestyles, changes in birth modalities, nutritional transition and therapeutic attitudes. A large fraction of the human population has tentatively entered a man-microbes dysbiotic state characterized by altered interactions between microbiome and host features with auto-aggravating crosstalk signals. The result is increased incidence of incurable immune-mediated diseases of modern societies that affect a third the human population on earth today and for which current therapeutics only address symptoms alleviation, rather than considering man as a holobiont.
In this context and its resulting threat for the human species, I will carry out a project geared to open a new era of individualized preventive care and novel gut ecology-based therapeutic approaches. The project will assemble insights and contributions from theoretical to experimental ecology, quantitative and functional microbiomics, preclinical work, cohort studies and clinical trials, so as to:
• Validate the concept of critical transition and alternative stable state as it applies to a shift from man-microbes symbiosis to disease-prone man-microbes dysbiosis
• Assess the potential of diet alone to promote such a shift
• Model the symbiosis-to-dysbiosis transitions and derive predictors of tipping points
• Propose counter-measures that may allow to break vicious circles and restore a balanced, health-prone, man-microbes symbiosis by concomitantly acting upon microbiome and host features
• Validate strategies to reinforce ecological robustness and restore man-microbes symbiosis
Based on a paradigm shift, the proposed work will set the grounds for future personalized preventive nutrition and clinical management considering man as a true holobiont.

Régimen de financiación

ERC-ADG - Advanced Grant

Institución de acogida

INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Aportación neta de la UEn
€ 2 291 014,00
Dirección
147 RUE DE L'UNIVERSITE
75007 Paris
Francia

Ver en el mapa

Región
Ile-de-France Ile-de-France Paris
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 2 491 014,00

Beneficiarios (2)